SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-220042
Filing Date
2014-05-30
Accepted
2014-05-30 17:00:05
Documents
12
Period of Report
2014-05-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d732426d8k.htm 8-K 24449
2 EX-23.1 d732426dex231.htm EX-23.1 2068
3 EX-23.2 d732426dex232.htm EX-23.2 1981
4 EX-99.1 d732426dex991.htm EX-99.1 460432
5 EX-99.2 d732426dex992.htm EX-99.2 70831
6 EX-99.3 d732426dex993.htm EX-99.3 706527
  Complete submission text file 0001193125-14-220042.txt   10222573

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT slxp-20131231.xml EX-101.INS 1615651
8 XBRL TAXONOMY EXTENSION SCHEMA slxp-20131231.xsd EX-101.SCH 77785
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE slxp-20131231_cal.xml EX-101.CAL 97109
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE slxp-20131231_def.xml EX-101.DEF 271637
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE slxp-20131231_lab.xml EX-101.LAB 682873
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slxp-20131231_pre.xml EX-101.PRE 454001
Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23265 | Film No.: 14881082
SIC: 2834 Pharmaceutical Preparations